XML 138 R120.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Financial Information (Parent Company Only) - Schedule of Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 18, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities        
Net income   $ 402,241 $ 392,929 $ 305,262
Items not requiring (providing) cash        
(Accretion)/ amortization   14,446 16,491 20,335
Share-based compensation   9,222 9,274 9,133
(Increase) decrease in value of equity securities   (2,971) 1,094 1,272
Changes in other assets   (22,806) (1,654) 9,342
Changes in other liabilities   (13,573) (724) 22,602
Net cash provided by operating activities   460,646 379,670 413,172
Cash flows from investing activities        
Purchases of premises and equipment, net   (38,531) (22,465) (19,579)
Purchases of equity securities   0 0 (49,975)
Redemptions of other investments   643 0 0
Net cash provided by (used in) investing activities   5,667 578,459 (1,024,270)
Cash flows from financing activities        
Retirement of subordinated debentures   0 0 (300,000)
Proceeds from issuance of subordinated debentures $ 296,400 0 0 296,324
Redemption of trust preferred securities   0 0 (96,499)
Proceeds from exercise of stock options   2,016 802 156
Repurchase of common stock   (86,493) (48,771) (70,856)
Dividends paid   (150,003) (145,904) (128,424)
Net cash (used in) provided by financing activities   (556,179) (682,706) (2,314,427)
Net change in cash and cash equivalents   (89,866) 275,423 (2,925,525)
Cash and cash equivalents – beginning of year   1,000,213 724,790 3,650,315
Cash and cash equivalents – end of year   910,347 1,000,213 724,790
Home BancShares        
Cash flows from operating activities        
Net income   402,241 392,929 305,262
Items not requiring (providing) cash        
(Accretion)/ amortization   (588) (586) 1,912
Share-based compensation   9,222 9,274 9,133
(Increase) decrease in value of equity securities   (2,971) 1,094 1,272
Equity in undistributed income of subsidiaries   (110,217) (84,869) (116,566)
Changes in other assets   (542) (364) (4,149)
Changes in other liabilities   (82) (155) 2,290
Net cash provided by operating activities   297,063 317,323 199,154
Cash flows from investing activities        
Purchases of premises and equipment, net   (221) 0 0
Net cash proceeds received – market acquisitions   0 0 201,428
Purchases of equity securities   0 0 (49,975)
Proceeds from sale of equity securities   3,436 1,522 13,778
Redemptions of other investments   0 0 2,899
Net cash provided by (used in) investing activities   3,215 1,522 168,130
Cash flows from financing activities        
Retirement of subordinated debentures   0 0 (300,000)
Proceeds from issuance of subordinated debentures   0 0 296,324
Redemption of trust preferred securities   0 0 (96,499)
Proceeds from exercise of stock options   2,016 802 156
Repurchase of common stock   (86,493) (48,771) (70,856)
Dividends paid   (150,003) (145,904) (128,424)
Net cash (used in) provided by financing activities   (234,480) (193,873) (299,299)
Net change in cash and cash equivalents   65,798 124,972 67,985
Cash and cash equivalents – beginning of year   484,542 359,570 291,585
Cash and cash equivalents – end of year   $ 550,340 $ 484,542 $ 359,570